Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson’s disease ; volume:242 ; number:1 ; day:1 ; month:11 ; year:2023 ; pages:25-32 ; date:1.2024
Experimental brain research ; 242, Heft 1 (1.11.2023), 25-32, 1.2024
- Urheber
-
Shen, Yufei
Zhu, Zhuoying
Wang, Yanping
Qian, Shuxia
Xu, Congying
Zhang, Baorong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00221-023-06709-3
- URN
-
urn:nbn:de:101:1-2024032515173722663994
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shen, Yufei
- Zhu, Zhuoying
- Wang, Yanping
- Qian, Shuxia
- Xu, Congying
- Zhang, Baorong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Role of the ubiquitin proteasome system in Parkinson's disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson’s disease
A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A
Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
STN DBS for Advanced Parkinson Disease Simultaneously Alleviates Cluster Headache
Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson’s disease models
Parkinson
Parkinson
MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Role of the ubiquitin proteasome system in Parkinson's disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson’s disease
A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A
Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
STN DBS for Advanced Parkinson Disease Simultaneously Alleviates Cluster Headache
Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson’s disease models
Parkinson
Parkinson
MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Role of the ubiquitin proteasome system in Parkinson's disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson’s disease
A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A
Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
STN DBS for Advanced Parkinson Disease Simultaneously Alleviates Cluster Headache
Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson’s disease models
Parkinson
Parkinson
MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease